ACADIA Pharmaceuticals
ACAD
#3520
Rank
S$5.14 B
Marketcap
S$30.41
Share price
-1.40%
Change (1 day)
20.05%
Change (1 year)

Market capitalization of ACADIA Pharmaceuticals (ACAD)

Market cap: S$5.14 Billion

As of February 2026 ACADIA Pharmaceuticals has a market cap of S$5.14 Billion. This makes ACADIA Pharmaceuticals the world's 3520th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ACADIA Pharmaceuticals from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026S$5.14 B-14.24%
2025S$5.99 B56.5%
2024S$3.83 B-43.53%
2023S$6.78 B96.44%
2022S$3.45 B-31.87%
2021S$5.07 B-54.89%
2020S$11.24 B25.55%
2019S$8.95 B181.81%
2018S$3.17 B-36.47%
2017S$5.00 B-1.05%
2016S$5.05 B-1.66%
2015S$5.14 B22.47%
2014S$4.19 B45.51%
2013S$2.88 B591.7%
2012S$0.41 B464.68%
2011S$73.85 M21.41%
2010S$60.82 M-14.37%
2009S$71.03 M48.45%
2008S$47.85 M-91.89%
2007S$0.58 B46.19%
2006S$0.40 B46.07%
2005S$0.27 B48.49%
2004S$0.18 B

End of Day market cap according to different sources

On Feb 4th, 2026 the market cap of ACADIA Pharmaceuticals was reported to be:

S$5.21 Billion
by Nasdaq info icon info icon
S$5.21 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$729.56 B 14,080.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$196.39 B 3,717.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$1.181 T 22,866.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$154.90 B 2,910.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
S$0.56 B-88.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
S$0.47 B-90.69%๐Ÿ‡บ๐Ÿ‡ธ USA